251 related articles for article (PubMed ID: 15342386)
1. Hath1, down-regulated in colon adenocarcinomas, inhibits proliferation and tumorigenesis of colon cancer cells.
Leow CC; Romero MS; Ross S; Polakis P; Gao WQ
Cancer Res; 2004 Sep; 64(17):6050-7. PubMed ID: 15342386
[TBL] [Abstract][Full Text] [Related]
2. A role for Hath1, a bHLH transcription factor, in colon adenocarcinoma.
Leow CC; Polakis P; Gao WQ
Ann N Y Acad Sci; 2005 Nov; 1059():174-83. PubMed ID: 16382053
[TBL] [Abstract][Full Text] [Related]
3. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index.
Wilson JW; Deed RW; Inoue T; Balzi M; Becciolini A; Faraoni P; Potten CS; Norton JD
Cancer Res; 2001 Dec; 61(24):8803-10. PubMed ID: 11751402
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer.
Tsuchiya K; Nakamura T; Okamoto R; Kanai T; Watanabe M
Gastroenterology; 2007 Jan; 132(1):208-20. PubMed ID: 17241872
[TBL] [Abstract][Full Text] [Related]
5. Hath1 inhibits proliferation of colon cancer cells probably through up-regulating expression of Muc2 and p27 and down-regulating expression of cyclin D1.
Zhu DH; Niu BL; Du HM; Ren K; Sun JM; Gong JP
Asian Pac J Cancer Prev; 2012; 13(12):6349-55. PubMed ID: 23464457
[TBL] [Abstract][Full Text] [Related]
6. [Hath1 gene transfer inhibits the proliferation of colonic cancer cells in vitro].
Zhu DH; Gong JP; Ren K; Sun JM; Wei SD
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1005-8. PubMed ID: 20501407
[TBL] [Abstract][Full Text] [Related]
7. Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis.
Gersemann M; Becker S; Kübler I; Koslowski M; Wang G; Herrlinger KR; Griger J; Fritz P; Fellermann K; Schwab M; Wehkamp J; Stange EF
Differentiation; 2009 Jan; 77(1):84-94. PubMed ID: 19281767
[TBL] [Abstract][Full Text] [Related]
8. HATH1 expression in mucinous cancers of the colorectum and related lesions.
Park ET; Oh HK; Gum JR; Crawley SC; Kakar S; Engel J; Leow CC; Gao WQ; Kim YS
Clin Cancer Res; 2006 Sep; 12(18):5403-10. PubMed ID: 17000673
[TBL] [Abstract][Full Text] [Related]
9. ING4 induces cell growth inhibition in human lung adenocarcinoma A549 cells by means of Wnt-1/beta-catenin signaling pathway.
Li X; Cai L; Liang M; Wang Y; Yang J; Zhao Y
Anat Rec (Hoboken); 2008 May; 291(5):593-600. PubMed ID: 18399550
[TBL] [Abstract][Full Text] [Related]
10. Hath1 up-regulates gastric mucin gene expression in gastric cells.
Sekine A; Akiyama Y; Yanagihara K; Yuasa Y
Biochem Biophys Res Commun; 2006 Jun; 344(4):1166-71. PubMed ID: 16647036
[TBL] [Abstract][Full Text] [Related]
11. E2F4 expression is required for cell cycle progression of normal intestinal crypt cells and colorectal cancer cells.
Garneau H; Paquin MC; Carrier JC; Rivard N
J Cell Physiol; 2009 Nov; 221(2):350-8. PubMed ID: 19562678
[TBL] [Abstract][Full Text] [Related]
12. P27KiP1 overexpression inhibits the growth and doxorubicin sensitivity of HT29 human colon cancer cells in vivo.
Dimanche-Boitrel MT; Micheau O; France D; Hammann A; Duchamp O; Genne P; Solary E
Anticancer Res; 2000; 20(2A):849-52. PubMed ID: 10810365
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cells.
Herynk MH; Stoeltzing O; Reinmuth N; Parikh NU; Abounader R; Laterra J; Radinsky R; Ellis LM; Gallick GE
Cancer Res; 2003 Jun; 63(11):2990-6. PubMed ID: 12782608
[TBL] [Abstract][Full Text] [Related]
14. Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity.
Xue J; Li X; Jiao S; Wei Y; Wu G; Fang J
Gastroenterology; 2010 Feb; 138(2):606-15. PubMed ID: 19786027
[TBL] [Abstract][Full Text] [Related]
15. Differential roles of Hath1, MUC2 and P27Kip1 in relation with gamma-secretase inhibition in human colonic carcinomas: a translational study.
Souazé F; Bou-Hanna C; Kandel C; Leclair F; Devallière J; Charreau B; Bézieau S; Mosnier JF; Laboisse CL
PLoS One; 2013; 8(2):e55904. PubMed ID: 23409082
[TBL] [Abstract][Full Text] [Related]
16. Protein Kinase-zeta inhibits collagen I-dependent and anchorage-independent growth and enhances apoptosis of human Caco-2 cells.
Mustafi R; Cerda S; Chumsangsri A; Fichera A; Bissonnette M
Mol Cancer Res; 2006 Sep; 4(9):683-94. PubMed ID: 16940160
[TBL] [Abstract][Full Text] [Related]
17. Targeted inactivation of p27kip1 is sufficient for large and small intestinal tumorigenesis in the mouse, which can be augmented by a Western-style high-risk diet.
Yang W; Bancroft L; Nicholas C; Lozonschi I; Augenlicht LH
Cancer Res; 2003 Aug; 63(16):4990-6. PubMed ID: 12941825
[TBL] [Abstract][Full Text] [Related]
18. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
19. Tumorigenesis in p27/p53- and p18/p53-double null mice: functional collaboration between the pRb and p53 pathways.
Damo LA; Snyder PW; Franklin DS
Mol Carcinog; 2005 Feb; 42(2):109-20. PubMed ID: 15584024
[TBL] [Abstract][Full Text] [Related]
20. Altered phenotype of HT29 colonic adenocarcinoma cells following expression of the DCC gene.
Velcich A; Corner G; Palumbo L; Augenlicht L
Oncogene; 1999 Apr; 18(16):2599-606. PubMed ID: 10353603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
